Centene Reports Q2 2026 Financial Results and Board Changes

Details

The company also increased its full-year 2026 guidance for GAAP diluted EPS to greater than $3.11 and for adjusted diluted EPS to greater than $4.80. Additionally, Director Kenneth Burdick resigned from the Board, and Paul Diaz was appointed as a new director, effective July 28, 2026.

Items reported

About Centene Corporation

Centene Corporation is a diversified healthcare enterprise providing a comprehensive range of managed care services to government-sponsored healthcare programs. Specializing in serving uninsured and underinsured populations, Centene offers health plans, benefits management, and other related services. It operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Medicaid, Medicare Advantage, and the Health Insurance Marketplace, impacting millions of lives across the United States. Meanwhile, the Specialty Services segment enhances healthcare quality and affordability through offerings such as pharmacy solutions, behavioral health, and optometry services. Founded in 1984 and headquartered in St. Louis, Missouri, Centene plays a significant role in the healthcare sector by addressing accessibility and cost challenges, thereby shaping market trends and influencing policy developments. As a major participant in the managed care industry, Centene is crucial for promoting coordinated care and improving health outcomes for vulnerable populations.